Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Efficacy and Safety of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy

NCT02284243 is registered in ClinicalTrials.gov with Baudax Bio as lead sponsor.

NCT NCT02284243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02284243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Efficacy and Safety of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy
Lead sponsor
Baudax Bio
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2014
Completion date
June 30, 2015
Enrollment
168 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pain, post-operative